Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 22.65% is 245% above its 5-year average of -15.63%, near the high end of its 5-year range (-59.47%–29.03%).
55.98% above its 12-month average of 14.52%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 15.05%.
GROSS MARGIN
22.65%
GROSS MARGIN AVG TTM
14.52%
GROSS MARGIN AVG 3Y
9.28%
GROSS MARGIN AVG 5Y
-15.63%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+55.98%
CURRENT VS 3Y AVG
+144.18%
CURRENT VS 5Y AVG
+244.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-45.03%
vs the sector median at left
Rapid Micro Biosystems, Inc.
Market Cap
$42.72M
Gross Margin
22.65%
TTM Avg
14.52%
3Y Avg
9.28%
5Y Avg
-15.63%
Market Cap
$42.83M
Gross Margin
-98.21%
TTM Avg
-96.12%
3Y Avg
-84.75%
5Y Avg
-75.83%
Market Cap
$42.26M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$41.95M
Gross Margin
93.13%
TTM Avg
94.29%
3Y Avg
92.05%
5Y Avg
80.64%
Market Cap
$44.02M
Gross Margin
56.09%
TTM Avg
52.85%
3Y Avg
42.50%
5Y Avg
40.42%
Market Cap
$44.71M
Gross Margin
75.20%
TTM Avg
76.17%
3Y Avg
74.22%
5Y Avg
71.65%
Market Cap
$44.72M
Gross Margin
0.00%
TTM Avg
1.89%
3Y Avg
44.91%
5Y Avg
29.94%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Rapid Micro Biosystems, Inc. (RPID) | $42.72M | 22.65% | 14.52% | 9.28% | -15.63% |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.83M | -98.21% | -96.12% | -84.75% | -75.83% |
| CVRx, Inc. (CVRX)vs › | $42.99M | 86.60% | 84.54% | 82.73% | 79.87% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.26M | 0.00% | 0.00% | 0.00% | 0.00% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | 93.13% | 94.29% | 92.05% | 80.64% |
| Precipio, Inc. (PRPO)vs › | $41.83M | 43.69% | 45.94% | 39.54% | 34.01% |
| DarioHealth Corp. (DRIO)vs › | $44.02M | 56.09% | 52.85% | 42.50% | 40.42% |
| SANUWAVE Health Inc. (SNWV)vs › | $44.71M | 75.20% | 76.17% | 74.22% | 71.65% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $44.72M | 0.00% | 1.89% | 44.91% | 29.94% |
| Celularity Inc. (CELU)vs › | $45.73M | 79.62% | 74.20% | 42.17% | 48.15% |
Gross Margin
22.6%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 15.05% |
| 2026-03-31 | 4.64% |
| 2025-12-31 | -2.92% |
| 2025-09-30 | 29.03% |
| 2025-06-30 | 26.81% |
| 2025-03-31 | 5.61% |
| 2024-12-31 | 11.94% |
| 2024-09-30 | 8.18% |
| 2024-06-30 | -2.86% |
| 2024-03-31 | -27.14% |
| 2023-12-31 | -2.71% |
| 2023-09-30 | -26.54% |
| 2023-06-30 | -37.82% |
| 2023-03-31 | -35.55% |
| 2022-12-31 | -59.47% |
| 2022-09-30 | -58.96% |
| 2022-06-30 | -31.63% |
| 2022-03-31 | -46.25% |
| 2021-12-31 | -49.65% |
| 2021-09-30 | -19.00% |
| 2021-06-30 | -29.00% |
| 2021-03-31 | -41.36% |
| 2020-12-31 | -60.25% |
| 2020-09-30 | -26.01% |
| 2020-06-30 | -61.28% |
| 2020-03-31 | -65.39% |
